Sep 21 | Mar 21 | Sep 20 | Mar 20 | Sep 19 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 12.65M | $ 12.09M | $ 10.35M | $ 13.81M | $ 6.70M |
Total Assets | $ 394.76M | $ 392.73M | $ 381.93M | $ 368.38M | $ 772.83M |
Total Debt | $ 34.79M | $ 35.21M | $ 34.73M | $ 34.50M | $ 31.39M |
Net Debt | $ 22.14M | $ 23.12M | $ 24.39M | $ 20.69M | $ 24.69M |
Total Liabilities | $ 80.19M | $ 79.68M | $ 71.99M | $ 69.38M | $ 407.89M |
Stockholders Equity | $ 314.57M | $ 313.05M | $ 309.94M | $ 299.01M | $ 332.11M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |